cis-4-Br-2,5-F2-PCPA

Name: cis-4-Br-2,5-F2-PCPA
Brand: TargetMol
SKU: T60359
Rating: 4.5 (1 reviews)

还可以

产品编号 T60359

cis-4-Br-2,5-F2-PCPA (S1024) 抑制 LSD1 和 LSD2，Ki 值分别为 94 nM 和 8.4 μM。癌症干细胞中 LSD1异常表达，cis-4-Br-2,5-F2-PCPA 能够通过增加 CCRF-CEM 细胞中二甲基化组蛋白 H3 的 K4 (H3K4) 水平，抑制 LSD1活性和癌细胞增殖。

cis-4-Br-2,5-F2-PCPA

还可以

产品编号 T60359

规格	价格	库存
25 mg	¥ 10,600	10-14周
50 mg	¥ 13,800	10-14周
100 mg	¥ 17,500	10-14周

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

联系我们获取更多批次信息

资源下载

产品操作手册

产品介绍

生物活性

产品描述

cis-4-Br-2,5-F2-PCPA (S1024) inhibits LSD1 and LSD2 with Ki values of 94 nM and 8.4 μM, respectively. There is aberrant expression of LSD1 in cancer stem cells, cis-4-Br-2,5-F2-PCPA inhibits LSD1 cell proliferation and by increasing the level of dimethylated histone H3 at K4 (H3K4) in CCRF-CEM cells [1].

体外活性

cis-4-Br-2,5-F2-PCPA (compound 7c) inhibits proliferation of the T-cell acute lymphoblastic leukemia (T-ALL) with IC 50 s of 12 μM (CCRF-CEM) and 16 μM (Jurkat) respectively, with no inhibitory effect on human normal fibroblast cell line WI-38 [1]. cis-4-Br-2,5-F2-PCPA (20 μM; 24 h) significantly increases the level of dimethylated H3K4 (H3K4me2), and exerts chemical inhibition on LSD1 and LSD2 [1]. Western Blot Analysis [1] Cell Line: T-cell acute lymphoblastic leukemia (T-ALL) Concentration: 20 μM Incubation Time: 24 hours Result: Increased the level of dimethylated H3K4 (H3K4me2) 2.9-fold compared with control.